Similar articles

• [APP, the causal gene for Alzheimer's disease].

  Tamaoka A, Kametani F. Tamaoka A, et al. Tanpakushitsu Kakusan Koso. 1996 Aug;41(10):1453-9. Tanpakushitsu Kakusan Koso. 1996. PMID: 8741396 Review. Japanese. No abstract available.
• The cytosolic domain of APP and its possible role in the pathogenesis of Alzheimer's disease.

  Minopoli G, Zambrano N, Russo T. Minopoli G, et al. Ital J Biochem. 2006 Sep-Dec;55(3-4):205-11. Ital J Biochem. 2006. PMID: 17274526 Review.
• A molecular approach to Alzheimer's disease.

  Multhaup G, Masters CL, Beyreuther K. Multhaup G, et al. Biol Chem Hoppe Seyler. 1993 Jan;374(1):1-8. Biol Chem Hoppe Seyler. 1993. PMID: 8439394 Review. No abstract available.
• High intracellular concentrations of amyloid-beta block nuclear translocation of phosphorylated CREB.

  Arvanitis DN, Ducatenzeiler A, Ou JN, Grodstein E, Andrews SD, Tendulkar SR, Ribeiro-da-Silva A, Szyf M, Cuello AC. Arvanitis DN, et al. J Neurochem. 2007 Oct;103(1):216-28. doi: 10.1111/j.1471-4159.2007.04704.x. Epub 2007 Jun 22. J Neurochem. 2007. PMID: 17587310
• Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.

  van Dijk R, Fischer DF, Sluijs JA, Sonnemans MA, Hobo B, Mercken L, Mann DM, Hol EM, van Leeuwen FW. van Dijk R, et al. J Neurochem. 2004 Aug;90(3):712-23. doi: 10.1111/j.1471-4159.2004.02528.x. J Neurochem. 2004. PMID: 15255950